Please assess the completion status of the following clinical trial:

Trial Title: Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate in People With Asthma

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Signed informed consent~* Outpatient at least 12 years of age with diagnosis of asthma at least 12 weeks before first visit~* Both genders; females of child bearing potential must be willing to use appropriate contraception during the study~* Pre-bronchodilator FEV1 of at least 60% predicted~* FEV1 reversibility of at least 12% and 200mls~* Current asthma therapy that includes a non-corticosteroid controller and/or short-acting beta agonist~Exclusion Criteria:~* History of life-threatening asthma exacerbation within the past 10 years~* Asthma exacerbation requiring treatment with oral corticosteroids within the last 3 months or that required overnight hospital stay within 6 months~* Current or recent respiratory infection or current oral candida infection~* Presence of another significant respiratory disease or medical condition that is not controlled or that could affect subject safety or study outcome~* Known or suspected allergy to study drug or materials~* Taking another investigational medication or prohibited medication during the study~* Previous treatment with inhaled fluticasone furoate in a phase II or III study~* Current smokers or former smokers with significant tobacco exposure~* Children in Care

- Gender: ALL
- Minimum Age: 12 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Fluticasone furoate 50mcg (Type: EXPERIMENTAL): Inhalation powder delivered by Novel Dry Powder Inhaler
- Placebo (Type: PLACEBO_COMPARATOR): Inhalation powder delivered by Novel Dry Powder Inhaler

Based on this trial design, predict the completion outcome and termination type (if applicable).